3.Bastos, ML, Lan, Z and Menzies, D (2017) An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis. European Respiratory Journal 49. .doi:10.1183/13993003.00803-2016.
4.Dookie, N et al. (2018) Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care. Journal of Antimicrobial Chemotherapy 73, 1138–1151.
5.Gegia, M et al. (2017) Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis. The Lancet Infectious Diseases 17, 223–234.
6.Allix-Béguec, C et al. (2008) Evaluation and strategy for use of MIRU-VNTRplus, a multifunctional database for online analysis of genotyping data and phylogenetic identification of Mycobacterium tuberculosis complex isolates. Journal of Clinical Microbiology 46, 2692–2699.
7.Papaventsis, D et al. (2017) Whole genome sequencing of Mycobacterium tuberculosis for detection of drug resistance: a systematic review. Clinical Microbiology and Infection 23, 61–68.
8.Chatterjee, A et al. (2017) Whole genome sequencing of clinical strains of Mycobacterium tuberculosis from Mumbai, India: a potential tool for determining drug-resistance and strain lineage. Tuberculosis 107, 63–72.
9.Coscolla, M and Gagneux, S (2014) Consequences of genomic diversity in mycobacterium tuberculosis. Seminars in Immunology 26, 431–444.
10.Gagneux, S (2018) Ecology and evolution of Mycobacterium tuberculosis. Nature Reviews Microbiology 16, 202–213.
11.Kato-Maeda, M, Metcalfe, JZ and Flores, L (2011) Genotyping of Mycobacterium tuberculosis: application in epidemiologic studies. Future Microbiology 6, 203–216.
13.Micheletti, VCD, Kritski, AL and Braga, JU (2016) Clinical features and treatment outcomes of patients with drug-resistant and drug-sensitive tuberculosis: a historical cohort study in Porto Alegre, Brazil. PLoS ONE 11, 1–13.
14.Van Embden, JDA et al. (1993) Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. Journal of Clinical Microbiology 31, 406–409.
15.Zhang, J et al. (2010) Mycobacterium tuberculosis complex CRISPR genotyping: improving efficiency, throughput and discriminative power of ‘spoligotyping’ with new spacers and a microbead-based hybridization assay. Journal of Medical Microbiology 59, 285–294.
16.de Beer, JL et al. (2012) First worldwide proficiency study on variable-number tandem-repeat typing of Mycobacterium tuberculosis complex strains. Journal of Clinical Microbiology 50, 662–669.
17.Supply, P et al. (2000) Variable human minisatellite-like regions in the Mycobacterium tuberculosis genome. Molecular Microbiology 36, 762–771.
18.Hunter, PR and Gaston, MA (1988) Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity. Journal of Clinical Microbiology 26, 2465–2466.
19.Glynn, JR, Vynnycky, E and Fine, PEM (1999) Influence of sampling on estimates of clustering and recent transmission of Mycobacterium tuberculosis derived from DNA fingerprinting techniques. American Journal of Epidemiology 149, 366–371.
20.Dalla Costa, ER et al. (2009) Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America. BMC Microbiology 9, 1–11.
21.Lazzarini, LCO et al. (2007) Discovery of a novel Mycobacterium tuberculosis lineage that is a major cause of tuberculosis in Rio de Janeiro, Brazil. Journal of Clinical Microbiology 45, 3891–3902.
22.Esteves, LS et al. (2018) Genetic diversity of Mycobacterium tuberculosis isoniazid monoresistant and multidrug-resistant in Rio Grande do Sul, a tuberculosis high-burden state in Brazil. Tuberculosis Elsevier Ltd 110, 36–43.
23.Seifert, M et al. (2015) Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic review. PLoS ONE 10, 1–13.
24.Zhang, Y and Yew, W (2009) Mechanisms of drug resistance in Mycobacterium tuberculosis. International Journal of Tuberculosis and Lung Disease 13, 1320–1330.
25.Hazbón, MH et al. (2006) Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 50, 2640–2649.
26.Monteserin, J et al. (2017) Relation of Mycobacterium tuberculosis mutations at katG315 and inhA-15 with drug resistance profile, genetic background, and clustering in Argentina. Diagnostic Microbiology and Infectious Disease 89, 197–201.
27.Nasiri, MJ et al. (2017) New insights in to the intrinsic and acquired drug resistance mechanisms in mycobacteria. Frontiers in Microbiology 8. .doi:10.3389/fmicb.2017.00681.
28.Isakova, J et al. (2018) Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic. BMC Microbiology 18, 1–8.
29.Perizzolo, PF et al. (2012) Characteristics of multidrug-resistant Mycobacterium tuberculosis in southern Brazil. Tuberculosis Elsevier Ltd 92, 56–59.
30.De Freitas, FAD et al. (2014) Multidrug resistant Mycobacterium tuberculosis: a retrospective katG and rpoB mutation profile analysis in isolates from a reference center in Brazil. PLoS ONE 9, 1–11.
31.Prim, RI et al. (2015) Molecular profiling of drug resistant isolates of Mycobacterium tuberculosis in the state of Santa Catarina, southern Brazil. Memorias do Instituto Oswaldo Cruz 110, 618–623.
32.Hameed, S et al. (2017) Sequence analysis of the rifampicin resistance determining region (RRDR) of rpoB gene in multidrug resistance confirmed and newly diagnosed tuberculosis patients of Punjab, Pakistan. PLoS ONE 12, 1–7.
33.Rossetti, MLR et al. (2017) An in silico study of a novel rpoB insertion in a cluster of clinical strains of Mycobacterium tuberculosis highly-rifampicin resistant. Preprints. .doi:10.20944/preprints201707.0078.v1.
34.Malshetty, V et al. (2010) Novel insertion and deletion mutants of RpoB that render Mycobacterium smegmatis RNA polymerase resistant to rifampicin-mediated inhibition of transcription. Microbiology (Reading, England) 156, 1565–1573.
35.Dalla Costa, ER et al. (2013) Mycobacterium tuberculosis of the RDRio genotype is the predominant cause of tuberculosis and associated with multidrug resistance in Porto Alegre City, South Brazil. Journal of Clinical Microbiology 51, 1071–1077.
36.Barbosa Cde, B et al. (2012) Tuberculosis caused by RDRio Mycobacterium tuberculosis is not associated with differential clinical features. International Journal of Tuberculosis and Lung Disease 16, 1377–1382.
37.Weisenberg, SA et al. (2012) Distinct clinical and epidemiological features of tuberculosis in New York City caused by the RDRio Mycobacterium tuberculosis sublineage. Infection, Genetics and Evolution 12, 664–670.
38.Brudey, K et al. (2006) Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiology 6, 1–17.
39.Filliol, I, Motiwala, A and Cavatore, M (2006) Global phylogeny of Mycobacterium tuberculosis based on single nucleotide polymorphism (SNP) analysis: insights into tuberculosis evolution, phylogenetic accuracy. Journal of Bacteriology 188, 759–772.
40.Yoder, MA, Lamichhane, G and Bishai, WR (2004) Cavitary pulmonary tuberculosis: The Holy Grail of disease transmission. Current Science 86, 74–81.
41.Chatterjee, A et al. (2010) Strains of Mycobacterium tuberculosis from Western Maharashtra, India, exhibit a high degree of diversity and strain-specific associations with drug resistance, cavitary disease, and treatment failure. Journal of Clinical Microbiology 48, 3593–3599.
42.Kempker, RR et al. (2012) Additional drug resistance in Mycobacterium tuberculosis isolates from resected cavities among patients with multidrug-resistant or extensively drug-resistant pulmonary tuberculosis. Clinical Infectious Diseases 54, 51–54.
43.Lazzarini, LCO et al. (2008) RDRio Mycobacterium tuberculosis infection is associated with a higher frequency of cavitary pulmonary disease. Journal of Clinical Microbiology 46, 2175–2183.
44.Perdigão, J et al. (2018) Clonal expansion across the seas as seen through CPLP-TB database: a joint effort in cataloguing Mycobacterium tuberculosis genetic diversity in Portuguese-speaking countries. Infection, Genetics and Evolution. .doi:10.1016/j.meegid.2018.03.011.
45.Dalla Costa, ER et al. (2015) Multidrug-resistant Mycobacterium tuberculosis of the Latin American Mediterranean lineage, wrongly identified as Mycobacterium pinnipedii (Spoligotype International Type 863 [SIT863]), causing active tuberculosis in South Brazil. Journal of Clinical Microbiology 53, 3805–3811.
46.Vasconcellos, SEG et al. (2014) Strain classification of mycobacterium tuberculosis isolates in Brazil based on genotypes obtained by spoligotyping, mycobacterial interspersed repetitive unit typing and the presence of large sequence and single nucleotide polymorphism. PLoS ONE 9. .doi:10.1371/journal.pone.0107747.
47.David, S et al. (2007) Contribution of spoligotyping to the characterization of the population structure of Mycobacterium tuberculosis isolates in Portugal. Infection, Genetics and Evolution 7, 609–617.
48.Viegas, SO et al. (2010) Molecular diversity of Mycobacterium tuberculosis isolates from patients with pulmonary tuberculosis in Mozambique. BMC Microbiology 10, 1–8.
49.Gagneux, S (2012) Host-pathogen coevolution in human tuberculosis. Philosophical Transactions of the Royal Society B: Biological Sciences 367, 850–859.
50.Wirth, T et al. (2008) Origin, spread and demography of the Mycobacterium tuberculosis complex. PLoS Pathogens 4. .doi:10.1371/journal.ppat.1000160.
51.Vluggen, C et al. (2017) Molecular epidemiology of Mycobacterium tuberculosis complex in Brussels, 2010–2013. PLoS ONE 12, 2010–2013.
52.Xu, G et al. (2018) Clustering and recent transmission of Mycobacterium tuberculosis in a Chinese population. Infection and Drug Resistance 11, 323–330.
53.Hamblion, EL et al. (2016) Recent TB transmission, clustering and predictors of large clusters in London, 2010–2012: results from first 3-years of universal MIRU-VNTR strain typing. Thorax 71, 749–756.
54.Borrell, S and Gagneux, S (2009) Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis. International Journal of Tuberculosis and Lung Disease 13, 1456–1466.
55.Coscolla, M and Gagneux, S (2010) Does M. tuberculosis genomic diversity explain disease diversity? Drug Discovery Today: Disease Mechanisms 7, e43–e59.
56.Chae, H and Shin, SJ (2018) Importance of differential identification of Mycobacterium tuberculosis strains for understanding differences in their prevalence, treatment efficacy, and vaccine development. Journal of Microbiology 56, 300–311.